Ocuphire Pharma's total assets for Q1 2024 were $51.84M, a decrease of -3.90% from the previous quarter. OCUP total liabilities were $5.79M for the fiscal quarter, a 43.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.